Tigermed
James Xie currently serves as a Senior Data Scientist at Tigermed, a position held since March 2023. Prior to this, James Xie was a Senior Data Scientist at Otsuka Pharmaceutical Companies (U.S.) from February 2024 to July 2025 and served as Senior Data Science Manager at Fate Therapeutics Inc from March 2022 to March 2023. James Xie also worked as a Data Scientist at AstraZeneca from February 2019 to March 2022. Earlier experience includes a role as Program Assessment Project Assistant at the University of Rochester from September 2015 to April 2016 and a Computer Research Analyst Intern at the City of New York during the summer of 2014. James Xie holds a Certificate of BioTech from the National Institute of Health (2019), a Master of Science in Data Science from the University of Virginia (2018), and a Bachelor's degree in Mathematics and Statistics from the University of Rochester (2017).
This person is not in any teams
This person is not in any offices
Tigermed
1 followers
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.